Objectives Several studies and reports support the health benefits of frequent physical exercise, on the condition that this exercise is controlled and maintained. Given the scarce resources that can be spent on health and health care, the objective of this study was to evaluate the long-term health and economic outcomes of controlled and maintained physical exercise in a fitness setting. Methods A 25-year Markov model with a 12-month cycle-length and states representing diabetes, coronary heart disease, stroke, colon cancer and breast cancer was developed to predict cumulative costs and QALYs (quality adjusted life years) for three defined population cohorts, of different risk levels. Physical exercise was thereby compared with no intervention. Reduced risks associated with physical exercise, cost of diseases and loss of quality of life in case of disease were obtained from published literature. Costs were taken from a societal perspective; Belgium was selected as the setting. One way and probabilistic sensitivity analyses were carried out. Results For each of the cohorts, physical exercise is predicted to increase the QALYs and to offset a large part of the initial investment. The cost per QALY varies from h2000 to 15 000 per QALY depending on the risk levels, which is better compared with a majority of secondary preventions that are currently publicly financed. Conclusion Controlled and maintained physical exercise is projected to be cost-effective, which is likely to be explained by its simultaneous effect on several diseases and the associated weight loss, which affects quality of life positively. Eur J Cardiovasc Prev Rehabil 14:815-824
Background and objectives
The health benefits of regular physical activity have been demonstrated by several authors. According to Paffenbarger et al. [1] , adequate and sustained lifetime exercise can add more than 2 life years. The study of Blair et al. [2] indicated that higher levels of physical fitness delay all-cause mortality, primarily due to lowered rates of cardiovascular disease and cancer. Several other authors reported strong evidence regarding the benefits of physical exercise in the prevention of prosperity diseases such as cardiovascular diseases, diabetes, high blood pressure, colon cancer and obesity [3] . Furthermore, the studies of Blair and coworkers [2] revealed that the beneficial effects of exercise, changing lifestyle from unfit to fit, are attainable for all age groups (from 20 to 60 years) and for all body mass index (BMI)-categories.
Substantial evidence is present that lack of physical fitness is related with absenteeism from work and with healthcare costs. Participation in a fitness centre was found to be an independent predictor for reduced absenteeism with fitness members having significant decreases in days of absenteeism [4] . Yen and colleagues [5] reported that employees who were physically inactive incurred almost double in medical claims compared with those who were physically active. A reverse causality cannot be excluded here, however (i.e. people with more medical claims have less time and energy to be physically active).
The recommended quantity of physical activity to obtain fitness and health benefits differs as a function of age. For adults the recommended quantity of physical activity to improve cardiorespiratory fitness is 30 min of aerobic exercise on 3-5 days a week at a moderate intensity [3] . Lower levels of physical activity, however, may equally reduce the risk for certain chronic degenerative diseases and improve the metabolic fitness without improving cardiorespiratory fitness. Besides aerobic fitness, muscular and flexibility training are also required.
Physical activity and training in the fitness setting offers different advantages compared with other types of physical activity. In contemporary fitness centres adherence is stimulated and a variety of activities is offered [6, 7] . Exercising is well oriented and functional (cardiorespiratory, muscular, flexibility), controlled, supervised and safe. Obviously, there are risks associated with physical activity and sports, such as injuries and accidents [8] . Figures from the insurance companies indicate that accidents in the fitness setting, however, are extremely low [9] .
To our knowledge, and despite all of the above evidence, a health economic evaluation of controlled and maintained physical exercise, simulating the resulting future health and economic consequences over time, has not been conducted so far.
Hence, the purpose of this paper is to describe the methods and results of a health economic model aiming at predicting the costs, savings and health benefits of controlled and maintained physical exercise over a time period of 10-25 years, for different types of target populations. Belgium was selected as the case country.
Design
The study is based on a state transition model, providing, for a selected cohort of individuals with a defined risk profile (see further) a forecast of life events (cardiovascular and oncological) in two scenarios: a scenario in the presence of physical activity within the cohort versus a scenario without physical activity.
Both scenarios have health and economic consequences, which are estimated based on available literature data.
In the model, we used the fitness setting, as physical exercise in this setting is functional, is considered as a lifetime activity and annual costs are predictable. Another advantage is the very low injury risk, as mentioned before.
We also assume that within this setting, adherence to exercise is improved [10, 11] .
The model was developed in the decision analytical software Tree Age Pro Suite 2004 (Tree Age Software Inc., Williamstown, Massachusetts, USA) and allows simulating different mutually exclusive health or disease states in which a person can be at a given point in time, and between which this person can progress. In the model, a person can (1) be healthy, (2) have coronary heart disease (CHD), (3) have cerebrovascular disease, (4) have diabetes, (5) have colon cancer or (6) have breast cancer.
Transitions from one state to another were allowed per cycle of 12 months, and were derived from literature data. These transitions depend on the risk level of a person or cohort and on the selected scenario, that is following an exercise programme or not. Each state from (2) to (6) is associated with extra costs and morbidity and/or reduced life expectancy. By reducing the probability to evolve to those states, by means of physical exercise, costs, and loss in quality of life and in life years are projected to be avoided. Importantly, throughout all states, the intervention ( = physical exercise) can influence the BMI of a person at any point in time, and as such the quality of life as well [12] .
Physical activity reduces the transitions to the above mentioned poor health states (see further). Obviously, this cannot be obtained for free, and currently individuals pay for membership at a fitness centre or for subscription to a programme.
In our study, we simulated the public payer subsidizing fitness to a given extent, and balanced this investment against the projected savings and the improved health condition of the cohort participating in the exercise programme(s).
The study is a cost-utility analysis, because the net costs of the exercise programme ( = investment costs minus savings in the long run due to avoiding complications) are balanced against the net benefits, the latter expressed in quality-adjusted life years (QALY) gained. A QALY is calculated by assigning the utility level to a life year. The utility level has a value between 0 ( = minimal value = death) and 1 ( = maximum value = perfect health). For instance, living a life year at a utility level of 0.8 is considered to be more of value than a life year at a level of 0.6. If such a quality improvement is maintained for 10 years, then 10 Â (0.8-0.6) = 2 QALYs are gained. By explicitly assigning a monetary value to a QALY, the study can also produce monetary results [13] .
With regard to the economic consequences, we considered both a public health payer and a societal perspective; in the first only including direct costs from the public healthcare payer's perspective, whereas in the latter, we also considered so-called indirect costs (mainly costs related to absenteeism as a result of a poor health condition). Possible travel costs and the opportunity cost of the time spent exercising were not taken into account.
The target population consists of persons or patients at different risk levels: for instance men and women with hypertension and/or hypercholesterolaemia and/or obesity. It was decided to select three well-defined target populations, which can be ranked from low to high risk. Table 1 shows the predicted risk for cardiovascular death for an average person in each of the cohorts, based on the so-called risk equation for low risk countries. This risk equation was developed by the European Society of Cardiology and allows to predict the incidence of cardiovascular death based on the risk profile of an individual [14] . Note that this table is only showing the cardiovascular mortality risk. As explained before, each individual may also die from breast cancer, colon cancer, diabetes, or other causes.
As a base case, we applied a 25-year analytical time horizon. A shorter time horizon of 10 years is often used in cardiovascular health economics, as in this time period the most relevant costs and outcomes associated with the prevention and management of cardiovascular events are usually covered. This time horizon of 10 years is also in line with the guidelines on the prevention of cardiovascular disease that relate treatment to a 10-year risk of events [15] . A longer time horizon is, however, justified here to better account for the effects on diabetes and cancer. Discounting of 3% is applied to future cost and effects [16] .
Model description
The model structure is presented in Fig. 1 .
All evaluated persons start the model without complications as described above. In the model, time is divided in fixed periods of 1 year. Each year a person has a risk of CHD defined as a fatal or nonfatal myocardial infarction (MI) or sudden death (not including unstable angina), stroke (fatal or not), colon cancer, breast cancer, diabetes or of dying from another cause. Note that the risk equation only predicts cardiovascular death and therefore, its predicted outcomes needed to be adjusted to predict the incidence of nonfatal events as well (see further).
If an event occurs, it is assumed in the model that it takes place in the half of the cycle (hence halfway the year). The risks (represented by the transition probabilities) depend on the considered scenario, that is whether or not the person is following a physical exercise programme or not. The clinical data used to populate the model are described further.
Individuals who suffered from a fatal event move to the 'death' state (which is technically called an absorbing state, as further evolution to other states is impossible), whereas those who underwent a first stroke move to the state 'stroke', and those suffering from a first nonfatal myocardial infarction event move to the state 'MI'; those in whom colon or breast cancer occur move to the states 'colon cancer' and 'breast cancer', respectively; those developing diabetes move to the state 'diabetes'; finally the remaining individuals stay in the 'no complications' state. Note that the model starts with 'persons', who become 'patients' once they have had an event.
Once patients have cardiovascular disease, they have again a (higher) risk to suffer from a new vascular event. These patients may have a nonfatal MI or stroke or die from a vascular or other cause.
Patients suffering from cancer move to a 'semi-absorbing' state, as they can only stay in this state or leave the state when they die.
Patients developing diabetes move to the health state 'diabetes' where they then have an increased risk to develop CHD, and stroke, not only maintain their risk for cancer, but also show an additional risk for microvascular disease.
Cost effectiveness of exercise depends on the baseline risk of CHD and other diseases in the studied population. Whereas the baseline risk of colon and breast cancer is only age and sex related, the baseline risk of CHD is related to several parameters, which can be defined in the model (age, sex, SBP, total cholesterol, smoking or not). The risk of developing diabetes is moreover based on the BMI level [17] .
Clinical and epidemiological data Cardiovascular disease
An overview of the cardiovascular clinical data applied in the model is shown in Table 2 . The 10-year risk of cardiac and noncardiac mortality based on age, sex, SBP, total cholesterol, and smoking can be calculated for any person using the Systematic Coronary Risk Evaluation (SCORE) equation [14] .
Once a CHD event occurs, it is found that about 26% of CHD events and 13% of cerebrovascular events are fatal [18, 19] .
For the further progression of cardiovascular disease after an event, the results of the aspirin group in the Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) trial [20] were used (we assume that after an event all individuals are treated with low-dose aspirin). In the CAPRIE trial, outcomes were reported not only for patients with a history of an ischaemic stroke, and of an MI, but also for the total cohort of patients with a history of a vascular event.
A plethora of data on the impact of exercise on CHD and stroke is available. For CHD, we opted to use the data provided by the Harvard Alumni Health Study, as this is a large long-term study (more than 7000 men, 7 years of follow-up), and it reports on the impact of several degrees of exercise [21] .
For the impact of exercise on stroke, results of the metaanalysis published in 2003 by Lee et al. [22] were used. This meta-analysis grouped all the information from 1966 to 2002 including 23 studies.
Cancer
Risks of colon and breast cancer in Belgium were derived from the National Cancer Registry (http://www.kankerregister.org/) and are age and sex related. Mortality data were provided by the Institute of Public Health (http:// www.iph.fgov.be/epidemio/morbidat/). All figures are shown in Table 3 and are reported per 100 000 individuals. The 5-year survival after diagnosis of breast cancer is 78%, and of colorectal cancer 46%, European Cancer Registry (EUROCARE III).
As reported by Katzmarzyk et al. [23] , physical inactivity increases the risk of those cancers with a factor 1.4 [95% confidence interval (CI) 1.3-1.5] and 1.2 (95% CI 1.0-1.5) for colon and breast cancer, respectively.
Diabetes
Incidence of diabetes related to body weight was provided by Warren et al. [17] and varies between 0.05 and 3.15% (see Table 4 ). Physical exercise decreases the risk of developing diabetes by 29% (95% CI 17%-37%) as reported by Katzmarzyk et al. [23] .
The annual risk of developing microvascular disease in diabetic patients is 0.67% [24] . Moreover the risk of cardiovascular disease is 30% higher in patients with diabetes (http://chdrisk.uni-muenster.de/). Table 5 shows the cost data input, both from a healthcare payer perspective and from a total societal perspective. Songer and Ettaro [25] reported that the direct costs and indirect costs in cerebrovascular disease are of the same magnitude and that in cardiac disease indirect costs count for 80% of direct costs. In diabetes this is 60%.
Cost data input
Cardiovascular disease cost data were obtained from published literature.
Lamotte et al. [26] conducted a patient chart review where the cost of patients dying from a cardiovascular cause was assessed for Belgium. In 2003, the average total cost of death from cardiovascular disease was h3744 (h3808 in 2004 using an annual inflation rate of 1.7%).
In a cost-effectiveness study of clopidogrel versus aspirin from the Belgian healthcare system perspective [27] , both acute and follow-up costs of MI and stroke were reported for the year 2002. Table 5 shows the costs per item.
For the cost of breast and colon cancer, a cost per year was calculated on the basis of the published sources [28, 29] .
The cost of type 2 diabetes, including microvascular and macrovascular complications in Belgium, was studied in the Cost of Diabetes in Europe-type 2 (CODE-2) and was used in a publication on obese patients [30] . Medical consumption data of 750 type 2 diabetes patients from 75 general practitioners were retrospectively registered for the second half of 1998. The costs were divided related to 1.19 37.0-38. 9 1.55 39.0-40. 9 2.00 41.0-42. 9 2.50 43.0-44. 9 3.15 EUROCARE:, European Cancer Registry. Source: Warren et al. [17] .
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the presence of complications (micro or macrovascular complications). To avoid double counting of costs owing to CHD events in the model we only used the cost of a patient without complications and the cost of microvascular disease.
Finally, the cost per year of subscription to a fitness centre was estimated to be about h500 leaving the individual the possibility to perform physical exercise as long and as frequent as he/she wants. In the analysis, we simulated different values between 0 and h500, depending on what percent of the total cost the government would subsidize.
Quality of life data input
The calculation of QALY requires the use of quality weights for each health state, also called utility levels [16] . Studies on the utility levels associated with different cardiovascular events are scarce. Moreover, it is not recommended to obtain utility data for different events from different sources, as the methods for measurement may vary between studies. Therefore, a study conducted by Coffey et al. [12] , whereby the independent effect of BMI and complications was assessed in diabetic patients, was selected as source of input for our model.
This study showed the independent effects on utility, as shown in Table 6 .
On the basis of studies by Warren et al. [17] we assumed that the utility of diabetic patients is 95% of that of nondiabetic patients.
The utility penalty for a breast cancer patient is on average 0.19 [31] and for a colon cancer patient, 0.27 [32] .
Sensitivity analysis
One-way sensitivity analysis was conducted on the time horizon, meaning that the final outcome was assessed for different time horizons of the model. Furthermore, the impact of compliance with the exercise program on final outcomes was assessed. Thereby, it was assumed that the drop in compliance would lead to a same drop in preventive effectiveness of physical exercise. For instance, a 20% drop in compliance would lead to a 20% drop in preventive effectiveness. Multivariate sensitivity analyses, whereby all variables are varied simultaneously, were performed for the cost of complications, and the effectiveness of physical exercise in reducing events. Table 7 shows the key results for the three types of cohorts, depending on BMI, cholesterol and hypertension level. As mentioned before, we varied the public payment for physical exercise between 0 and h500 per year and considered both direct as well as total costs. In all circumstances, the cost effectiveness is well below a threshold of h20 000 per QALY gained, which is a commonly cited level of societal willingness to pay for healthcare in Belgium. The results are systematically better from a societal perspective, as, from this perspective the incurred costs of events are higher, leading to additional savings with physical exercise.
Results
The most cost-effective results are obtained in cohort 3, as was expected. In this cohort, when a societal perspective is taken, the cost of physical exercise up to a level of h400 per year is completely compensated by future savings. Table 8 shows that the time horizon has little effect on outcomes. This is explained by the observation that with longer time horizons, a larger investment is also required, which appears to be proportional with the larger savings and health benefits obtained. The compliance, on the contrary, has an important impact, if it is assumed that a relative drop in compliance leads to a same drop in preventive effectiveness. Assuming a 25 years time horizon, a drop in compliance of 50% leads to a worsening of the incremental cost-effectiveness ratio to h25 235, h22 175 and h16 358 per QALY for cohorts 1, 2 and 3, respectively (Table 9 ).
When the 25 years time horizon is taken and cohort 1 is considered, the simultaneous variation of clinical data around their CI and cost data by ± 20% results in the scatterplot as shown in Fig. 2 . For instance, the relative risk (RR) of CHD was 0.60 with a CI of 0.44-0.83.
The figure shows that in all cases the incremental costutility ratio is below the h20 000 per QALY threshold.
Discussion
The results of this analysis show that controlled exercise offers value for money, even if society would cover for its expenses completely. Interestingly, even in young, slightly overweight patients, clear QALY benefits are observed. The average person in cohort 1 is a relatively healthy person, however, is overweight. The results point to cost effectiveness: if society would be paying for the fitness programme of this person, the cost per QALY gained would be h13 920 if the full cost of physical exercise would be covered. This is very cost effective compared with many existing pharmaceutical interventions in healthcare.
For instance, the cost-effectiveness ratio of the generally accepted cholesterol lowering therapy with statins in secondary prevention of coronary artery disease was h5838-17 868 in Belgium [33] . Another trial in the same disease area [34] , found an incremental cost-effectiveness ratio for n-3 polyunsaturated fatty acids of h24 603 (1999 values) per life-year gained (95% CI: h22 646-h26 930) in secondary prevention after MI.
In the second cohort, the risk is clearly higher, and the results are logically better. Yet, the net cost is still ± h3000, when h300 per year would be subsidized. Hence, ± 2/3rd of the total investment is gained back due to avoiding future events. Although this is a very good result, a net saving or break-even cannot be obtained. We believe that this is partially due to the survival paradox: as people will live longer on average, they induce more costs in the long run.
In the highest risk cohort, net savings can be obtained up to a public payment of h400.
Interestingly, variation of the time horizon does not influence cost effectiveness, as explained by the observation that with longer time horizons also a larger investment is required, which appears to be proportional with the larger savings and health benefits obtained. Obviously, given these results, the longer the physical exercise is maintained, the better from a health perspective.
The study, however, has some limitations. First, a modelling approach was required given the lack of prospective long-term data including all possible considered events. The advantage of modelling is that all inputs and relationships can be included and varied. The disadvantage is that predictive validity can only be assessed in the future (e.g. by organizing a large prospective trial of very long duration). This can be compensated by conducting extensive sensitivity analysis, preferably a probabilistic multivariate analysis. By performing such an analysis, it was shown that the results are robust, as shown by the fact that all the plausible results are below the h20 000 per QALY threshold, which supports the validity of the conclusions, and the value of physical exercise in comparison with many currently applied secondary prevention strategies.
It could be argued that a population attributable risk approach could have been used, as this parameter is often used for estimating the effect on disease rates of removing a risk factor from the population [35] . In our project, however, we preferred to apply the RR approach, because we consider the impact of one risk factor on many diseases (CHD, stroke, diabetes, breast and colon cancer), rather than the impact of many risk factors on one disease, and because the RR values were readily available from literature.
The model assumed 100% compliance with physical exercise. This level of compliance is difficult to obtain in real life. Compliance, however, is likely to improve if the government would link the payment to exercise adherence. The latter implies equally an adequate and transparent control system from the fitness industry, ensuring a qualitative and adherence stimulating support, and a conditional post hoc payment system, whereby the individual receives the payment only on condition that he/she can demonstrate sufficient compliance to the program. According to our calculations (Table 9 ), this compliance should at least be 80%.
Third, only three cohorts were considered and hence, it is not recommended to extrapolate the obtained results to the entire population. Yet, the considered cohorts varied from quite low to quite high risk levels and results are therefore applicable to all cohorts who show in between values. Rather than extrapolating, the analysis allows to intrapolate results to different other populations.
Fourth, we did not take into account the cost of travel time or time spent exercising. A recent paper by Van den Hout et al. [36] suggests that the sum of these two items (travel and time spent exercising) represents an important part ( ± 20%) of the total societal cost of exercising in arthritis patients. The authors did not split between the two components (travel and time spent), however, but it can be assumed that travel time will be lower than time spent exercising. It is moreover questionable whether the latter should really be considered as an opportunity cost as the alternative way of spending this time may be very 'inactive'.
Finally, risks for colon or breast cancer were based on age and sex. Hence, the impact a possible family history of either cancer might have on the results was not assessed. A simple approach could be to increase the incidence rates of either cancer by a factor associated with family history. This would likely improve the results of the model for the particular target population, because the starting risk is higher, leading to a larger absolute benefit of physical exercise, if the relative benefit is assumed constant. On the contrary, a policy of physical exercise focussing on this specific target population may lead to stigmatization.
In conclusion, on the basis of the three cases considered, our model suggests that organized fitness is very cost effective over a wide range of populations, if those populations are comparable with the Belgian one.
If sufficient compliance can be obtained (for instance by a post hoc payment), then our results suggest that subsidizing controlled and sustained physical exercise will lead to more health, at a very beneficial cost-effectiveness ratio, and that money invested in this area is betterinvested money compared with many other areas.
The exact level of government intervention will depend on the importance the government assigns to the avoided diseases. Indeed, it has been shown that governments are willing to pay more per QALY in the case of severe diseases. Finally, the total budgetary impact will play an important role in the final decision and further research with this regard is required. 
